Skip to main content
. 2021 Dec 31;12(1):56. doi: 10.3390/biom12010056

Figure 3.

Figure 3

Dysbiosis of gut microbiota may explain the inflammatory process and hepatotoxicity of microbiome-derived compounds implicated in the pathogenesis of NAFLD. Abbreviations: FFA, Free Fatty Acids; LPS, Lipopolysaccharide; NAFLD, Non-Alcoholic Fatty Liver Disease; NSAIDs, Non-Steroid Anti-Inflammatory Drugs; SCFAs, Short-chain Fatty Acids; TMAO, Trimethylamine N-oxide. (All images are originated from the free medical website http://smart.servier.com/ by Servier licensed under a Creative Commons Attribution 3.0 Unported License, accessed on 1 October 2021).